Cognitive Impairment and Dementia in Patients with Parkinson Disease

By  

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 10, 2009-07 ,pp. : 903-912

Bentham Science Publishers

Access to resources Recommend Favorite

The role of infectious agents in pulmonary and systemic vascular disease

By Egermayer Paul  

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 7, 2001-07 ,pp. : 1093-1097

Informa Healthcare

Access to resources Recommend Favorite

Galantamine in the Treatment of Cognitive Decline in Patients with Vascular Dementia or Alzheimer’s Disease with Cerebrovascular Disease

By Small G.  

CNS Drugs, Vol. 17, Iss. 12, 2003-01 ,pp. : 905-914

Adis International

Access to resources Recommend Favorite

Lanthanum-induced neurotoxicity: solving the riddle of its involvement in cognitive impairment?

By Zarros Apostolos   Byrne Ashleigh-Maria   Boomkamp Stephanie   Tsakiris Stylianos   Baillie George  

Archives of Toxicology, Vol. 87, Iss. 11, 2013-11 ,pp. : 2031-2035

Springer Publishing Company

Access to resources Recommend Favorite

NMDA Neurotransmission Dysfunction in Mild Cognitive Impairment and Alzheimer’s Disease

By  

Current Pharmaceutical Design, Vol. 20, Iss. 32, 2014-10 ,pp. : 5169-5179

Bentham Science Publishers

Access to resources Recommend Favorite